Loading organizations...
§ Private Profile · Seattle, WA, USA
Tumor response assessment technology for drug efficacy evaluation.
Presage Biosciences has raised $27.0M across 3 funding rounds.
Presage Biosciences has raised $27.0M in total across 3 funding rounds.
Presage Biosciences has raised $27.0M across 3 funding rounds. Most recently, it raised $13.0M Other Equity in March 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 2, 2021 | $13M Venture Round | — | Bristol Myers Squibb, Inharv Partners, Labcorp, Takeda Ventures | Announced |
| Jul 18, 2018 | $6M Series D | Celgene, Takeda | — | Announced |
| Mar 21, 2013 | $8M Venture Round | — | — | Announced |
Presage Biosciences has raised $27.0M in total across 3 funding rounds.
Presage Biosciences's investors include Bristol Myers Squibb, InHarv Partners, Labcorp, Takeda Ventures, Celgene, Takeda.